Short Stature in Iran

  • Siamak Shiva
  • Afshin Ghalehgolab Behbahan


Public health programs have succeeded in many achievements in Iran over the past two decades. Now, Iranians’ health indicators generally exceed most regional averages. A health-care network serves the integrated program of primary health for Iranian families residing in rural and urban areas. Presently in the absence of growth charts that are specifically constructed for Iranian children and adolescents, physicians and health-care services use NCHS charts for growth monitoring and assessing height status in pediatric population. 11% of Iranian urban children less than 5 years of age and 21.8% of their rural peers have moderate to severe stunting. Short stature most commonly presents between 12 and 23 months of age, when its prevalence is considerably greater in rural (27.3%) than in urban (13.9%) areas. According to different reports from various parts of the country, 45–85.5% of diagnosed short statures have been due to non-pathologic causes. Growth hormone deficiency (GHD) is the most common endocrine cause of short stature in Iran, followed by hypothyroidism as the second common etiology. The rates of GHD and hypothyroidism among Iranian short children range from 6 to 30% and 2.5 to 12%, respectively. The heights of about 45% of patients with beta-thalassemia major in Iran are 2 SD below the mean for age and sex based on NCHS growth charts. The prevalence of short stature in thalassemic patients increases progressively with advancing age. Zinc deficiency is one of the most prevalent micronutrient insufficiencies in developing countries, including Iran. Its prevalence varies in different parts of Iran; nevertheless, it is more common in rural areas, correlating with the rate of stunting. Turner syndrome is the most common chromosomal abnormality associated with short stature that comprises about 1.3–13.5% of short girls referred to pediatric endocrinology clinics in Iran. Although the most common problem encountered by Iranian pediatric endocrinologists is short stature, about 35% of children referred to pediatric endocrinologists for evaluation of short stature are not truly short but rather have a normal growth velocity. Short stature is still a major endocrine problem in Iran; however, it seems that the stature of Iranian children has been improving over the last decades. During 1990s the average height of Iranian girls and boys between 2 and 18 years of age has increased about 3.6 cm.


Short Stature Osteogenesis Imperfecta Zinc Deficiency Growth Hormone Deficiency Congenital Adrenal Hyperplasia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Constitutional growth delay


Familial short stature


Growth hormone


Growth hormone deficiency


Idiopathic short stature


Intrauterine growth retardation


National Center for Health Statistics


Standard deviation score


  1. Afshar-Peiman Sh, Moayeri H. Prevalence of growth hormone deficiency in children with short stature. Iran J Pediatr. 2004;14:89–93. (Persian)Google Scholar
  2. Ebrahimi S, Pormahmodi A, Kamkar A. Study of zinc supplementation on growth of school children in Yasuj, Southwest of Iran. Pak J Nutr. 2006;5:341–342.CrossRefGoogle Scholar
  3. Farzianpour F, Rabbani A, Batabi A, Rasouli J, Amini Kashani M. Role of health management in evaluation of programs monitoring the growth of children aged 0–5 in Tehran, Iran. Pak J Nutr. 2009;8:829–834.CrossRefGoogle Scholar
  4. Fesharakinia A, Zarban A, Sharifzadeh GR. Prevalence of zinc deficiency in elementary school children of South Khorasan province (East Iran). Iran J Pediatr. 2009;19:249–254.Google Scholar
  5. Hakimi SM, Hashemi F, Valaei N, Kimiagar SM, Velayati AA, Boloursaz MR. The effect of supplemental zinc on the height and weight percentiles of children. Arch Iranian Med. 2006;9:148–152.Google Scholar
  6. Heydari ST, Emamghoreishi F, Amini M. Infant’s growth charts in Jahrom, Iran. Iran J Pediatr. 2009;19:25–34.Google Scholar
  7. Jalilolghadr S, Kashanipoor N, Javadi M. The effect of zinc supplementation on linear growth in short stature school-aged children in Qazvin. J Qazvin Univ Med Sci. 2008;12:13–19. (Persian)Google Scholar
  8. Karimi M, Karamifar HA. Short stature in beta-thalassemia major subjects. Med Sci Monit. 2004;10:603–605.Google Scholar
  9. Mahmoodi MR, Kimiagar SM. Prevalence of zinc deficiency in junior high school students of Tehran city. Biol Trace Elem Res. 2001;81:93–103.PubMedCrossRefGoogle Scholar
  10. Ministry of Health and Medical Education in collaboration with UNICEF. Improvement of children’s growth and nutrition. Iran ministry of health, Tehran: Iran ministry of health;. 2001. (Persian)Google Scholar
  11. Moayeri H, Aghighi Y. A prospective study of etiology of short stature in 426 short children and adolescents. Arch Iranian Med. 2004;7:23–27.Google Scholar
  12. Mohammad K, Hosseini M, Noorbala AA. Secular trends in growth (weight and height) of children in Iran over a decade (1990–1 to 1999). Res J Hakim. 2006;9:1–8. (Persian)Google Scholar
  13. Mohammadian S, Khoddam H, Nematollahi MR. An etiologic evaluation of children with short stature in Gorgan (North-East Iran, 2005). Gorgan J Med Sci. 2007;10:65–70. (Persian)Google Scholar
  14. Montazerifar F, Karajibani M, Mohammadi M. Comparison of growth pattern in children under 6 years with standard National Center for Health Statistics (NCHS). J Tabibe Shargh. 2005;7:39–47. (Persian)Google Scholar
  15. Nakhjavani M, Esteghamati A, Ziaei A. Evaluation of frequency growth failure in patients referred to endocrine clinic of Imam Hospital 1997–98. J Tehran Med Sch. 2001;2:23–26. (Persian)Google Scholar
  16. Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pourzahedgilani N, Bouzari N, Habibzadeh MR, Hashemi R, Shamshirsaz AHA, Aghakhani S, Homayoun H, Larijani B. Metabolic and endocrine complications in beta-thalassemia major: a multicenter study in Tehran, Iran. BMC Endocrine Disorders. 2003;3:4.PubMedCrossRefGoogle Scholar
  17. Sharbatdar-Alaei MR, Rabbani A, Rezaei M, Nourbakhsh MK. Etiological profile of short stature in a referral endocrinology clinic. Iran J Pediatr. 2007;17:61–66. (Persian)Google Scholar
  18. Sharifi F, Hedayati M, Mirmiran P. The serum level of zinc, Cu, iron in elementary students of 23 province of Iran in 1996. Iran J Endocr Metab. 1999;1:275–285. (Persian)Google Scholar
  19. Shiva S, Nikzad A. Etiology of short stature in East Azerbaijan, Iran. Iran J Pediatr. 2009;19:35–40.Google Scholar
  20. Shiva S, Sarisorkhabi R. Short stature in patients with ß-thalassemia major. Urmia Med J. 2008;19:125–31. (Persian)Google Scholar
  21. Soheilikhah S, Halvani AH. Study on etiology of short stature in 7–15 years old referrals to Yazd endocrine clinic during years 1997–2000. Yazd Med J. 2001;3:3–9. (Persian)Google Scholar
  22. Ziaaddini H, Amirkhani MA, Komsari F, Ardalan G, Roozbehani R, Poursafa P, Klishadi R. Frequency of short stature in six years old children in year 2007. J Isfahan Med School. Suppl Health advance. 2008:438–444. (Persian)Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Pediatric Health Research Center, Tabriz Children’s HospitalTabriz University of Medical Sciences & Health ServicesTabrizIran
  2. 2.Faculty of MedicineTabriz University of Medical Sciences & Health Services,TabrizIran
  3. 3.Children’s HospitalTabrizIran

Personalised recommendations